[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100469226":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":20,"responsibleParty":43,"collaborators":47,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":57,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":7,"studyType":69,"phases":7,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"University of Luebeck","OTHER",null,[9,15],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":14},"Julia Vogler, Dr.","CONTACT","+49 451 500","44639","Julia.vogler@uksh.de",{"name":16,"role":11,"phone":17,"phoneExt":18,"email":19},"Cornelia Wolf","+49451500","44540","cornelia.wolf@uksh.de",[21],{"facility":22,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Clinic for Rhythmology","RECRUITING","Lübeck","Schleswig-Holstein","23538","Germany","DE",{"type":30,"coordinates":31},"Point",[32,33],10.68729,53.86893,{"lat":33,"lon":32},[36,39],{"name":37,"role":11,"phone":17,"phoneExt":13,"email":38},"Julia S Vogler, Dr.med.","julia.vogler@uksh.de",{"name":40,"role":11,"phone":17,"phoneExt":41,"email":42},"Mirco Kuechler","77075","mirco.kuechler@uksh.de",{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Prof. Roland Richard Tilz","Prof. Dr. med. Roland Richard Tilz",[48,51,53],{"name":49,"class":50},"Prof. Jürgen Kuschyk, M.D","UNKNOWN",{"name":52,"class":50},"Giovanni Forleo, M.D.",{"name":54,"class":50},"Mauro Biffi, M.D.","100469226","the-international-subcutaneous-implantable-cardioverter-defibrillator-registry-isusi-100469226",false,"NCT05390047","The International SubcutaneouS Implantable Cardioverter Defibrillator Registry (iSuSI)","The International Subcutaneous Implantable Cardioverter Defibrillator Registry (iSuSi)","iSuSI","Inclusion Criteria:\n\n* Implantation of an S-ICD, regardless of the technique\n* At least 1 month of follow up\n* At least 1 post-implantation assessment, in accordance to the routine clinical practice of every center (e.g. in person visit or remote follow up)\n\nExclusion Criteria:\n\n\\- none","ALL","18 Years","99 Years",{"count":67,"type":68},4000,"ESTIMATED","OBSERVATIONAL","The entirely subcutaneous implantable defibrillator (S-ICD) (Emblem, Boston Scientific, Marlborough, MA, USA) was introduced as a new therapeutic alternative to the conventional transvenous ICD in 2009 and implantations are rapidly expanding since then.1 Implantation of the S-ICD seems to reduce implant-related perioperative complications such as pneumothorax, hematoma and cardiac tamponade.\n\nThe aim of this multicenter registry is thus to assess the outcome of patients following an S-ICD implantation in a real-world setting.",[72],"Sudden Cardiac Death",[74],"subcutaneous implantable cardioverter defibrillator","2024-06-28",{"date":77,"type":78},"2024-07-01","ACTUAL",{"date":80,"type":78},"2022-07-01",{"date":82,"type":68},"2025-09-30",{"name":5,"class":6},1]